Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Elixinol Announce Appointments of Global General Counsel & Company Secretary (ASX:EXL)

Highlights Appointment of Teresa Cleary as Global General Counsel and Company Secretary Resignation of Ron Dufficy as Company Secretary and Kim Bradley-Ware as Joint Company Secreta...read more

Elixinol Global Announce Quarterly Report and Appendix 4C (ASX:EXL)

ELIXINOL GLOBAL LIMITED Q3 FY2019 APPENDIX 4C AND QUARTERLY BUSINESS UPDATE NORMALISED REVENUE GROWTH OF 12% ON Q3 FY2018 KEY HIGHLIGHTS: Q3 FY2019 group revenue of $9.6m1, represents ...read more

Elixinol Announce Market Update on Elixinol Japan Operations (ASX:EXL)

Market Update – Elixinol Japan Operations Elixinol Global Limited (Elixinol Global or the Company) (ASX:EXL; OTCQX:ELLXF), today announces that the Company has established that non-compliant ...read more

Elixinol Global, Trading Halt (ASX:EXL)

The securities of Elixinol Global Limited (‘EXL’) will be placed in trading halt at the request of EXL, pending it releasing an announcement. Unless ASX decides otherwise, the securities...read more

Elixinol Global, Pause in Trading (ASX:EXL)

Trading in the securities of the entity will be temporarily paused pending a further announcement. For more information, download the attached PDF.

Elixinol Global, Upcoming U.S. Investor Conferences (ASX:EXL)

Elixinol Global Limited (Elixinol Global or the Company) (ASX:EXL; OTCQX:ELLXF), a global company operating in the industrial hemp and emerging medicinal cannabis sectors, is attending the following...read more

Elixinol Global, Exclusive Distribution Agreement for Finland (ASX:EXL)

Elixinol Global Limited (Elixinol Global) (ASX:EXL; OTCQX:ELLXF) is pleased to announce that its Dutch based wholly-owned subsidiary, Elixinol BV (Elixinol), has signed an exclusive distribution agr...read more

EcoQuest, Cynata Therapeutics - CEO Presentation: Becoming a Next Generation Stem Cell Company (ASX:ECQ)

Stem Cell Field is Emerging Analogous to monoclonal antibody enabling technologies in ‘80s and ‘90s which now have a therapeutic market value in excess of US$44.6b; Commercial s...read more

EcoQuest Ltd, Prospectus (ASX:ECQ)

Chairman's Letter On behalf of the Directors of Eco Quest Limited (to be renamed Cynata Therapeutics Limited) (Company), I am delighted to invite you to participate in an issue of Shares to...read more

Empire Oil & Gas: Response to ERM Proposal (ASX:EGO)

INITIAL RESPONSE TO THE ERM POWER LIMITED’s PROPOSAL TO CHANGE THE EMPIRE OIL & GAS NL BOARD The Directors of Empire Oil & Gas NL (“Empire”) or (“the ...read more

EcoQuest Ltd, Chairman's Letter & Presentation (ASX:ECQ)

Dear Shareholder, On behalf of the Directors of Eco Quest Ltd (“Company”) I am pleased to advise that on Monday 23 September 2013 Eco Quest exercised the options to acquire the rem...read more

EcoQuest Ltd, Options to Acquire Stem Cell Company Cynata Inc Exercised (ASX:ECQ)

Highlights: - Eco Quest moves to acquire 100% of Cynata Inc; - Company name proposed to be changed to Cynata Therapeutics Limited; - Cynata licensed technology: unique, pr...read more

Empire Oil & Gas NL, Total Cost of Construction and Commissioning of the Red Gully Gas and Condensate Processing Facility (ASX:EGO)

Empire Oil & Gas NL announces the total cost of the construction of the Red Gully Gas and Condensate Processing Facility including commissioning is AU$38.679 million. Currently, the Red Gul...read more

EcoQuest, CEO Presentation (ASX:ECQ)

Overview - Cynata Inc is a California registered company with rights to certain novel stem cell technology licensed from Wisconsin University Alumni Research Foundation (WARF) - ...read more

Empire Oil & Gas NL, Approval to Drill Dunnart-2, EP437, North Perth Basin, Western Australia (ASX:EGO)

Empire Oil & Gas NL (“Empire”) as Operator of Exploration Permit EP437 is pleased to announce that the Western Australian Department of Mines and Petroleum (DMP) has granted Approva...read more

Viewing: 166 - 180 of 200 Previous | Next